Results 251 to 260 of about 12,793,395 (292)

Serum CA 19-9 and CA 50 antigens in hemodialysis patients.

Clinical nephrology, 1987
Serum concentrations of monoclonal antibody-defined tumor markers CA 19-9 and CA 50 were measured in 64 uncomplicated hemodialysis patients (Group 1) and in 8 hemodialysis patients with cancer (Group 2) in comparison with corresponding CEA determinations.
D, Docci, E, Pistocchi, F, Turci, L, Baldrati, S, Urbini, S, Scaioli   +5 more
openaire   +1 more source

CA 19–9, GICA (Gastrointestinal Cancer Antigen)

1992
Following the detection and clinical exploitation of alphafetoprotein (AFP), calcinoembryonic antigen (CEA), and human chorionic genadotropin (HCG) as first and basic tumor markers, the discovery of blood group-related carbohydrate structures on glycoproteins and glycolipids as indicators of malignancy has opened a wide array of scientific and clinical
openaire   +1 more source

Serum levels of the oncofetal antigens CA-125, CA 19-9 and CA 15-3 in patients with endometriosis

Journal of Endocrinological Investigation, 1988
The levels of the oncofetal antigens CA-125, CA 19-9 and CA 15-3 were measured in serum samples taken from 8 women, aged 21 to 37 yr, before treatment, during the last fifteen days of a 6-month administration of danazol and finally three months after treatment withdrawal.
D, Panidis, G, Vlassis, J, Matalliotakis, S, Skiadopoulos, A, Kalogeropoulos   +4 more
openaire   +2 more sources

[Immunohistochemical determination of antigen 19-9 (CA 19-9) in transitional carcinoma of the bladder].

Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 1993
Carbohydrate Antigen 19-9 (CA 19-9) histological expression in transitional cell bladder carcinoma (TCBC) was studied by means of immunohistochemistry and its findings compared with those of Tissue Polypeptidic Antigen (TPA) and Carcino Embryonic Antigen (CEA).
G, Casetta, A, Cavallini, P, Piana, L, Squintone, M, Vottero, A, Tizzani   +5 more
openaire   +1 more source

Vorkommen der tumorassoziierten Antigene CA 50 und CA 19-9 in Endometriumkarzinomen

Archives of Gynecology and Obstetrics, 1993
Das tumorassoziierte Antigen CA 19-9 entspricht dem sialysierten Lewisa Blutgrup- penantigen. Das Antigen CA 50 setzt sich aus diesem Epitop und einer weiteren Zuckergruppe zusammen. Serumbestimmungen von CA 19-9 und CA 50 eignen sich zur Verlaufskontrolle von Pankreas- und Dickdarmkarzinomen (Nakagoe et al.; Schwenk et al.).
U. -J. Göhring, F. Weber, A. Scharl, A. Bolte   +3 more
openaire   +1 more source

[Tissue expression of carbohydrate antigen 19-9 (CA 19-9) in adenomatous lesions of the colorectum].

Chirurgia italiana, 1999
Serum levels of tumor markers almost not detectable in precancerous states or early cancer, the behavior of the tumor associated antigen CA 19-9 in colorectal carcinogenesis was analysed. In order to investigate the adenoma-carcinoma sequence, tissue antigenic expression was measured in adenomas, characterized by different size and histology, and ...
G F, Tucci, M, Grande, I, Stroppa, F, Federico, A M, Farinon   +4 more
openaire   +1 more source

[Carbohydrate antigen CA 19-9: value in pancreatic pathology].

Gastroenterologie clinique et biologique, 1986
In order to determine the diagnostic usefulness of the dosage of carbohydrate antigen (CA 19-9) serum levels in pancreatic diseases, 38 patients with pancreatic lesions proved at laparotomy were studied. Pancreatic lesions were classified into two groups: a) group I: pancreatic adenocarcinoma (17 cases) b) group II: benign pancreatic diseases (21 cases)
J, Venot, D, Vincent, A, Gainant, B, Descottes, F, Cessot, C, Beck   +5 more
openaire   +1 more source

19-9 carbohydrate antigenic determinant (CA 19-9): a tool for digestive cancer diagnosis ?

1987
info:eu-repo/semantics ...
Amir, Roland, Bourdoux, Pierre, Delhaye, Marie, Thys, Olivier   +3 more
openaire   +1 more source

The clinical utility of the CA 19-9 tumor-associated antigen.

The American journal of gastroenterology, 1990
Since Koprowski and coworkers discovered the CA 19-9 antigen 10 yr ago, it has become the most useful blood test in the diagnosis and management of patients with cancer of the pancreas. With an upper limit of normal of 37 U/ml, the assay's overall sensitivity is approximately 80% and its specificity is 90%.
openaire   +1 more source

Critical care management of chimeric antigen receptor T-cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Sandrine Valade, Peter Schellongowski, Alexander Shimabukuro-Vornhagen   +2 more
exaly